LOS ANGELES, CALIFORNIA – February 18, 2021 – GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS human and asset tracking systems and a supplier of Health and Safety personal protective medical equipment “PPE”, announced today it has begun the distribution of a Rapid Diagnostic Test-Kits for Antigens. The highly accurate, 10-minute results COVID-19 Antigen test is approved under the Emergency Use Authorization (“EAU”) and tests for the detection of Antigens specific to SARS-CoV-2.
The COVID-19 Antigen test (www.gtxmask.com) is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of symptom onset.
Key Attributes of the Rapid Test Kit:
- Approved under the EAU act.
- Made in the U.S.A.
- Test results within 10 minutes.
- No Lab required; test-kit comes with everything you need.
“As the vaccine rollout continues, we see testing becoming an integral part of that process. Whether you need to test to get on a plane, due to the recently mandated travel requirements, or if you want to test your antibodies to see if you ever had COVID, low-cost rapid test kits are going to play a big role in getting back to normal over the next 12 months. Adding the “Made in the U.S.A.” rapid SARS-CoV-2 Antigen test to our rapid Antibody test kits, expands our existing assortment of essential health & safety products, is part of our ongoing commitment to bringing the marketplace the “best-in-class” products and services”, stated GTX Corp CEO, Patrick Bertagna.
The Company widely known for its flagship, award winning and patented GPS SmartSole, a safety and security GPS monitoring and tracking solution for those who suffer from Alzheimer’s, dementia, autism, TBI and other memory disorders, is expected to announce the launch of its newly engineered 4G LTE model sometime this quarter. They will come in three trim to fit sizes for adults and children, made with state-of-the-art electronic components and a ruggedized water resistant encasement, all assembled in Rhode Island, U.S.A.
GTX also distributes an extensive line of Personal Protective Equipment “PPE”, owns and licenses a portfolio of patents in the GPS and wearable technology space, and is a GSA-approved military and government supplier. Many of the Company’s products are available at its online store and Amazon, and GTX recently soft launched its NFC Veritap solution. To find out more about how you can buy or become an authorized reseller of GTX products, contact our info@gtxcorp.com business development office.
Remember the 3 W’s to reduce the risks of COVID -Wear a mask, Wash your hands and Watch your distance.
MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include GunAlert the world’s first all in one firearm safety solution gun lock with patented motion sensor and GPS theft recovery. And the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.